Saturday, Sep 6, 2025
Search
Hyderabad
Telangana
AP News
India
World
Entertainment
Sport
Science and Tech
Business
Rewind
...
NRI
View Point
cartoon
My Space
Olympics
Education Today
Reviews
Property
Lifestyle
E-Paper
NRI
View Point
cartoon
My Space
Reviews
Education Today
Property
Lifestyle
"granules-india-limited"
Granules India Limited receives final approval from USFDA for its new drug
Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and pediatric patients aged six years and older, as well as for Moderate to Severe Binge Eating Disorder (BED) in adults
Latest News
Hyderabad: Richmond Villas Ganesh laddu auctioned for record Rs 2.32 crore
13 mins ago
Vedanta’s takeover of Jaiprakash Associates raises concerns over SLBC tunnel project
27 mins ago
Horoscope: Find out your star predictions today, Sept 6, 2025
35 mins ago
Bengaluru devotee donates over Rs 1 crore to TTD’s health scheme
52 mins ago
Manoj Manchu all set for a fierce comeback with Mirai
59 mins ago
Balapur Ganesh laddu fetches record Rs 35 lakh at auction
17 mins ago
Hyderabad Ganesh procession delayed, Balapur idol to cross Charminar after 1 pm
1 hour ago
Rashmika Mandanna calls early morning flights her ‘hardest’ daily decision
2 hours ago
.